Last CNY51.40 CNY
Change Today +0.75 / 1.48%
Volume 1.4M
300347 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).

hangzhou tigermed consulti-a (300347) Snapshot

Open
CNY50.50
Previous Close
CNY50.65
Day High
CNY51.80
Day Low
CNY50.30
52 Week High
05/6/13 - CNY60.38
52 Week Low
08/16/12 - CNY18.94
Market Cap
5.5B
Average Volume 10 Days
2.7M
EPS TTM
CNY0.76
Shares Outstanding
106.8M
EX-Date
05/2/13
P/E TM
67.6x
Dividend
CNY0.40
Dividend Yield
0.78%
Current Stock Chart for HANGZHOU TIGERMED CONSULTI-A (300347)

Related News

No related news articles were found.

hangzhou tigermed consulti-a (300347) Related Businessweek News

No Related Businessweek News Found

hangzhou tigermed consulti-a (300347) Details

Hangzhou Tigermed Consulting Co., Ltd. operates as a contract research organization in China and internationally. It offers clinical trials services, including biometrics services across various phases of clinical trials in the areas of oncology, endocrinology, CNS, virology, and cardiology. The company provides clinical trial services, such as clinical trial planning, management, and implementation; essential documents preparation; study start-up; site clinical study agreement; monitoring; project management; safety report; QA and QC; and clinical study report writing. It also offers data management services, including CRF design, data management plan development, study database setup and validation, double data entry, computerized edit check, medical coding, discrepancy generation and resolution, blind review and database lock, and neCRF design and EDC system management. In addition, the company provides services in the area of biostatistics, such as statistical considerations and sample size calculation in protocol development; randomization list generation; statistical analysis plan development; SAS programming of statistical tables, listings, and figures; interim analysis; statistical analysis report writing; and final report review by statistician, as well as services in the area of regulatory affairs, including regulatory feasibility study, documents sorting and submission, sample testing arrangement, and IND and NDA tracking. Further, it offers medical translation services comprising handling inter-translations of Chinese, English, Japanese, Korean, and Spanish, as well as provision of written translation and simultaneous translation; and GCP training services for sponsors, research institutions, and clinical research professionals. Hangzhou Tigermed Consulting Co., Ltd. serves pharmaceutical, biopharmaceutical, and medical device companies. The company was founded in 2004 and is headquartered in Hangzhou, the People’s Republic of China.

Founded in 2004

hangzhou tigermed consulti-a (300347) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

hangzhou tigermed consulti-a (300347) Key Developments

Hangzhou Tigermed Consulting Co., Ltd. Approves Amendments to the Articles of Association

Hangzhou Tigermed Consulting Co., Ltd. announced that at its first extraordinary general meeting of 2013 held on May 13, 2013, shareholders approved the amendments to the company's articles of association.

Hangzhou Tigermed Consulting Co., Ltd. Proposes Amendments to Articles of Association

Hangzhou Tigermed Consulting Co., Ltd. announced to consider amendments to the company's articles of association at its first extraordinary general meeting of 2013 to be held on May 13, 2013.

Hangzhou Tigermed Consulting Co., Ltd., Special/Extraordinary Shareholders Meeting, May 13, 2013

Hangzhou Tigermed Consulting Co., Ltd., Special/Extraordinary Shareholders Meeting, May 13, 2013., at 10:00 China Standard Time. Agenda: To consider change of the company's registered capital and amendments to the company's articles of association; and to consider guarantee for joint-stock companies.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300347:CH CNY51.40 CNY +0.75

300347 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
PAREXEL International Corp $46.19 USD +0.51
WuXi PharmaTech Cayman Inc $20.89 USD 0.00
View Industry Companies
 

Industry Analysis

300347

Industry Average

Valuation 300347 Industry Range
Price/Earnings 65.6x
Price/Sales 20.1x
Price/Book 7.7x
Price/Cash Flow 73.1x
TEV/Sales 18.0x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HANGZHOU TIGERMED CONSULTI-A, please visit www.tigermed.net. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.